3: Greenwood-Van Meerveld B, Tyler K, Mohammadi E, Pietra C
doi:10.1002/mabi.202200019 Canapp SO, Farese JP, Schultz GS, et al
This dietary supplement drink product contains 2,000 mg L-carnitine per serving
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand names Ozempic and Rybelsus) and chronic weight management (Wegovy)
Conventional corticosteroids, disease-modifying anti-rheumatic medications (DMARDs), such as methotrexate and hydroxychloroquine, non-steroidal antirheumatic drugs (NSAIDs), such as indomethacin, ibuprofen, aspirin, etc., and immunosuppressive agents like TNF- and IL-6 inhibitors, are presently included in the treatment regime 9,11,12,13,14,15